Andrew Bellinger

Insider Reports History

Entity
Individual
Location
500 Technology Square, Cambridge, MA
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Andrew Bellinger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Bellinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 45K $450K $10.00 Feb 14, 2024 Direct
Verve Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 180K Feb 14, 2024 Direct

Insider Reports Filed by Andrew Bellinger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERV Verve Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 16, 2024 Chief Scientific Officer
VERV Verve Therapeutics, Inc. Feb 14, 2023 1 $0 4 Feb 16, 2023 CSO & CMO
VERV Verve Therapeutics, Inc. Dec 14, 2022 2 $103K 4 Dec 16, 2022 CSO & CMO
VERV Verve Therapeutics, Inc. Dec 1, 2022 1 -$19.9K 4 Dec 2, 2022 CSO & CMO
VERV Verve Therapeutics, Inc. Oct 28, 2022 3 -$384K 4 Nov 1, 2022 CSO & CMO
VERV Verve Therapeutics, Inc. Sep 23, 2022 8 -$2.03M 4 Sep 27, 2022 CSO & CMO
VERV Verve Therapeutics, Inc. Jul 20, 2022 3 -$670K 4 Jul 22, 2022 CSO & CMO
VERV Verve Therapeutics, Inc. Jul 13, 2022 3 -$234K 4 Jul 15, 2022 CSO & CMO
VERV Verve Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 Chief Scientific Officer
VERV Verve Therapeutics, Inc. Dec 22, 2021 5 -$558K 4 Dec 27, 2021 Chief Scientific Officer
VERV Verve Therapeutics, Inc. Dec 16, 2021 1 $0 4 Dec 17, 2021 Chief Scientific Officer
VERV Verve Therapeutics, Inc. Jun 17, 2021 2 $95K 4 Jun 21, 2021 Chief Scientific Officer
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Chief Scientific Officer